Rank | Gene Set | Z-score |
---|---|---|
1 | autophagic vacuole fusion (GO:0000046) | 5.37599199 |
2 | metallo-sulfur cluster assembly (GO:0031163) | 5.36503731 |
3 | iron-sulfur cluster assembly (GO:0016226) | 5.36503731 |
4 | sphingomyelin metabolic process (GO:0006684) | 5.22144151 |
5 | organelle membrane fusion (GO:0090174) | 4.95456413 |
6 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.80792368 |
7 | auditory receptor cell differentiation (GO:0042491) | 4.75840435 |
8 | energy homeostasis (GO:0097009) | 4.25778686 |
9 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.80537916 |
10 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.80537916 |
11 | S-adenosylmethionine metabolic process (GO:0046500) | 3.76798136 |
12 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.68288460 |
13 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.56021398 |
14 | negative regulation of monooxygenase activity (GO:0032769) | 3.54778289 |
15 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.50151376 |
16 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.46787632 |
17 | regulation of vitamin metabolic process (GO:0030656) | 3.43750692 |
18 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.32579524 |
19 | regulation of B cell apoptotic process (GO:0002902) | 3.26634827 |
20 | GMP metabolic process (GO:0046037) | 3.25601660 |
21 | positive regulation of prostaglandin secretion (GO:0032308) | 3.21389424 |
22 | L-phenylalanine metabolic process (GO:0006558) | 3.20295652 |
23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.20295652 |
24 | GDP-mannose metabolic process (GO:0019673) | 3.19931434 |
25 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.19095162 |
26 | protein prenylation (GO:0018342) | 3.17743343 |
27 | prenylation (GO:0097354) | 3.17743343 |
28 | respiratory electron transport chain (GO:0022904) | 3.16596243 |
29 | electron transport chain (GO:0022900) | 3.15539006 |
30 | negative regulation of B cell apoptotic process (GO:0002903) | 3.14922883 |
31 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.13734902 |
32 | L-phenylalanine catabolic process (GO:0006559) | 3.13734902 |
33 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 3.12202064 |
34 | rRNA modification (GO:0000154) | 3.06610636 |
35 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.05482797 |
36 | ATP synthesis coupled proton transport (GO:0015986) | 3.05482797 |
37 | cellular response to vitamin D (GO:0071305) | 3.03028606 |
38 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.00372540 |
39 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.00372540 |
40 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.00349879 |
41 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.98904404 |
42 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.98852027 |
43 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.97577498 |
44 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.97577498 |
45 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.97577498 |
46 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.97146314 |
47 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.97146314 |
48 | RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503) | 2.96278665 |
49 | positive regulation of ligase activity (GO:0051351) | 2.95890860 |
50 | positive regulation of lamellipodium assembly (GO:0010592) | 2.95576584 |
51 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.95495989 |
52 | signal peptide processing (GO:0006465) | 2.90978698 |
53 | negative regulation of oxidoreductase activity (GO:0051354) | 2.90423218 |
54 | regulation of mitochondrial translation (GO:0070129) | 2.86549893 |
55 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.86192256 |
56 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.86192256 |
57 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.84720517 |
58 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.83156671 |
59 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.82939151 |
60 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.82377475 |
61 | glycerol ether metabolic process (GO:0006662) | 2.81481611 |
62 | positive regulation of lamellipodium organization (GO:1902745) | 2.79923070 |
63 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.78298493 |
64 | NAD biosynthetic process (GO:0009435) | 2.77639672 |
65 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.76289902 |
66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.75903559 |
67 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 2.74613134 |
68 | protein complex biogenesis (GO:0070271) | 2.74514084 |
69 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.73455015 |
70 | negative regulation of ligase activity (GO:0051352) | 2.73455015 |
71 | mitochondrial respiratory chain complex assembly (GO:0033108) | 2.67148099 |
72 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.66042885 |
73 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.65087686 |
74 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.64882431 |
75 | negative regulation of stress fiber assembly (GO:0051497) | 2.64859453 |
76 | ether metabolic process (GO:0018904) | 2.63427925 |
77 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.60665725 |
78 | hydrogen ion transmembrane transport (GO:1902600) | 2.58302733 |
79 | cellular response to zinc ion (GO:0071294) | 2.58020647 |
80 | regulation of cellular amine metabolic process (GO:0033238) | 2.57651785 |
81 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.57277956 |
82 | regulation of prostaglandin secretion (GO:0032306) | 2.55807517 |
83 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.55696894 |
84 | nucleoside transport (GO:0015858) | 2.53930003 |
85 | GPI anchor biosynthetic process (GO:0006506) | 2.53075722 |
86 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.50751342 |
87 | positive regulation of fatty acid transport (GO:2000193) | 2.50643627 |
88 | proteasome assembly (GO:0043248) | 2.48492805 |
89 | aromatic amino acid family catabolic process (GO:0009074) | 2.47613520 |
90 | positive regulation of mRNA catabolic process (GO:0061014) | 2.46972676 |
91 | omega-hydroxylase P450 pathway (GO:0097267) | 2.46969759 |
92 | negative regulation of cell size (GO:0045792) | 2.45564081 |
93 | ether lipid metabolic process (GO:0046485) | 2.44876888 |
94 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.44840985 |
95 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.44840985 |
96 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.43435842 |
97 | tetrahydrofolate metabolic process (GO:0046653) | 2.41493774 |
98 | cytochrome complex assembly (GO:0017004) | 2.40166336 |
99 | positive regulation of cell cycle arrest (GO:0071158) | 2.40059077 |
100 | detection of chemical stimulus involved in sensory perception of taste (GO:0050912) | 2.39441715 |
Rank | Gene Set | Z-score |
---|---|---|
1 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 4.41510425 |
2 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.48811623 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.47203932 |
4 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.86528923 |
5 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.75106237 |
6 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.71941685 |
7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.65005851 |
8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.64259953 |
9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.58234367 |
10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.58113053 |
11 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.46711054 |
12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.14156042 |
13 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.09749705 |
14 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.06616212 |
15 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.05962596 |
16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.00807493 |
17 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97564070 |
18 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.94170456 |
19 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.93095329 |
20 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.91983622 |
21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.89675970 |
22 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.89091334 |
23 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.84217898 |
24 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.72825944 |
25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.72180836 |
26 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.67689287 |
27 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.63226860 |
28 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.61583520 |
29 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55654399 |
30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.53917228 |
31 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.51222035 |
32 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.49513090 |
33 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.48912102 |
34 | VDR_22108803_ChIP-Seq_LS180_Human | 1.48852570 |
35 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.48710945 |
36 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.47846823 |
37 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.45471223 |
38 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41377861 |
39 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.40686728 |
40 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.39909023 |
41 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.36682396 |
42 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.34178308 |
43 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.33565421 |
44 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.33157946 |
45 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.33105451 |
46 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.32431195 |
47 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.30493813 |
48 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.29588644 |
49 | P300_27268052_Chip-Seq_Bcells_Human | 1.28951579 |
50 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.28754206 |
51 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.28096792 |
52 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.26645530 |
53 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.25940439 |
54 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.25835695 |
55 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.25650759 |
56 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.24212421 |
57 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.22931543 |
58 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22041734 |
59 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.21104727 |
60 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.21087629 |
61 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.19423091 |
62 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.16384116 |
63 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.16334875 |
64 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.15670379 |
65 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.14912804 |
66 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.14688244 |
67 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.14339350 |
68 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.14291049 |
69 | P68_20966046_ChIP-Seq_HELA_Human | 1.13489494 |
70 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.12091846 |
71 | RAC3_21632823_ChIP-Seq_H3396_Human | 1.10912575 |
72 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.10387434 |
73 | P53_21459846_ChIP-Seq_SAOS-2_Human | 1.08124090 |
74 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07449885 |
75 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.05413429 |
76 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.04550671 |
77 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.03649150 |
78 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.03153511 |
79 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02733508 |
80 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.02250351 |
81 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.00735387 |
82 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.00590844 |
83 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.00078784 |
84 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.99150969 |
85 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98790758 |
86 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.98346557 |
87 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.98316330 |
88 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97967092 |
89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.97533800 |
90 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.97097814 |
91 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.96913584 |
92 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.96893519 |
93 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96200590 |
94 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.95320010 |
95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94770623 |
96 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.93343369 |
97 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.92705155 |
98 | AR_20517297_ChIP-Seq_VCAP_Human | 0.91722858 |
99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.91042002 |
100 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 0.90383858 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005451_abnormal_body_composition | 4.68850698 |
2 | MP0003195_calcinosis | 4.25990329 |
3 | MP0002138_abnormal_hepatobiliary_system | 3.90335709 |
4 | MP0002139_abnormal_hepatobiliary_system | 3.49181163 |
5 | MP0010386_abnormal_urinary_bladder | 3.13339698 |
6 | MP0009780_abnormal_chondrocyte_physiolo | 2.69085515 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 2.62248450 |
8 | MP0005084_abnormal_gallbladder_morpholo | 2.54417928 |
9 | MP0005058_abnormal_lysosome_morphology | 2.45826497 |
10 | MP0003806_abnormal_nucleotide_metabolis | 2.40816966 |
11 | MP0006072_abnormal_retinal_apoptosis | 2.35395284 |
12 | MP0005083_abnormal_biliary_tract | 2.33008765 |
13 | MP0003283_abnormal_digestive_organ | 2.12108838 |
14 | MP0003300_gastrointestinal_ulcer | 2.04829480 |
15 | MP0005220_abnormal_exocrine_pancreas | 2.03535735 |
16 | MP0005365_abnormal_bile_salt | 1.90899842 |
17 | MP0002837_dystrophic_cardiac_calcinosis | 1.89368889 |
18 | MP0006035_abnormal_mitochondrial_morpho | 1.89135381 |
19 | MP0004147_increased_porphyrin_level | 1.86494396 |
20 | MP0006036_abnormal_mitochondrial_physio | 1.86334021 |
21 | MP0003724_increased_susceptibility_to | 1.79773817 |
22 | MP0003436_decreased_susceptibility_to | 1.65872756 |
23 | MP0005670_abnormal_white_adipose | 1.61783045 |
24 | MP0001533_abnormal_skeleton_physiology | 1.59358550 |
25 | MP0002148_abnormal_hypersensitivity_rea | 1.52179401 |
26 | MP0003075_altered_response_to | 1.47006775 |
27 | MP0009840_abnormal_foam_cell | 1.44886219 |
28 | MP0005000_abnormal_immune_tolerance | 1.39301079 |
29 | MP0001873_stomach_inflammation | 1.38469838 |
30 | MP0009785_altered_susceptibility_to | 1.35497509 |
31 | MP0002132_abnormal_respiratory_system | 1.34798922 |
32 | MP0009046_muscle_twitch | 1.33833839 |
33 | MP0006054_spinal_hemorrhage | 1.30247227 |
34 | MP0005389_reproductive_system_phenotype | 1.30065168 |
35 | MP0005410_abnormal_fertilization | 1.29781425 |
36 | MP0003186_abnormal_redox_activity | 1.27404968 |
37 | MP0005360_urolithiasis | 1.26863473 |
38 | MP0001661_extended_life_span | 1.24814747 |
39 | MP0002168_other_aberrant_phenotype | 1.23608894 |
40 | MP0001790_abnormal_immune_system | 1.22538091 |
41 | MP0005387_immune_system_phenotype | 1.22538091 |
42 | MP0008260_abnormal_autophagy | 1.20604788 |
43 | MP0001845_abnormal_inflammatory_respons | 1.19168083 |
44 | MP0001666_abnormal_nutrient_absorption | 1.18129402 |
45 | MP0003045_fibrosis | 1.17020717 |
46 | MP0000685_abnormal_immune_system | 1.16856222 |
47 | MP0008872_abnormal_physiological_respon | 1.16028560 |
48 | MP0005395_other_phenotype | 1.15319244 |
49 | MP0005023_abnormal_wound_healing | 1.15122961 |
50 | MP0002160_abnormal_reproductive_system | 1.10803930 |
51 | MP0003763_abnormal_thymus_physiology | 1.09798040 |
52 | MP0005332_abnormal_amino_acid | 1.09645228 |
53 | MP0006082_CNS_inflammation | 1.07341184 |
54 | MP0009764_decreased_sensitivity_to | 1.06691863 |
55 | MP0009643_abnormal_urine_homeostasis | 1.06377671 |
56 | MP0002405_respiratory_system_inflammati | 1.05374305 |
57 | MP0000358_abnormal_cell_content/ | 1.04963241 |
58 | MP0002163_abnormal_gland_morphology | 1.04852588 |
59 | MP0003718_maternal_effect | 1.02705786 |
60 | MP0005636_abnormal_mineral_homeostasis | 1.02629014 |
61 | MP0005319_abnormal_enzyme/_coenzyme | 0.99433629 |
62 | MP0001545_abnormal_hematopoietic_system | 0.98139307 |
63 | MP0005397_hematopoietic_system_phenotyp | 0.98139307 |
64 | MP0008004_abnormal_stomach_pH | 0.97406479 |
65 | MP0001919_abnormal_reproductive_system | 0.96882576 |
66 | MP0002876_abnormal_thyroid_physiology | 0.95750981 |
67 | MP0010155_abnormal_intestine_physiology | 0.95440700 |
68 | MP0009333_abnormal_splenocyte_physiolog | 0.95264647 |
69 | MP0000013_abnormal_adipose_tissue | 0.95170668 |
70 | MP0004742_abnormal_vestibular_system | 0.95003500 |
71 | MP0004808_abnormal_hematopoietic_stem | 0.93639120 |
72 | MP0003183_abnormal_peptide_metabolism | 0.92365184 |
73 | MP0002693_abnormal_pancreas_physiology | 0.92342721 |
74 | MP0008469_abnormal_protein_level | 0.91922643 |
75 | MP0000538_abnormal_urinary_bladder | 0.91868773 |
76 | MP0002452_abnormal_antigen_presenting | 0.91036137 |
77 | MP0001664_abnormal_digestion | 0.91021242 |
78 | MP0005551_abnormal_eye_electrophysiolog | 0.88172132 |
79 | MP0005025_abnormal_response_to | 0.88034320 |
80 | MP0001800_abnormal_humoral_immune | 0.86666119 |
81 | MP0002723_abnormal_immune_serum | 0.85608143 |
82 | MP0003786_premature_aging | 0.84579416 |
83 | MP0004782_abnormal_surfactant_physiolog | 0.83615766 |
84 | MP0001944_abnormal_pancreas_morphology | 0.82695613 |
85 | MP0005464_abnormal_platelet_physiology | 0.82585145 |
86 | MP0005671_abnormal_response_to | 0.79983119 |
87 | MP0005165_increased_susceptibility_to | 0.78833728 |
88 | MP0010329_abnormal_lipoprotein_level | 0.78474531 |
89 | MP0005166_decreased_susceptibility_to | 0.77268579 |
90 | MP0001542_abnormal_bone_strength | 0.76198008 |
91 | MP0002419_abnormal_innate_immunity | 0.75926920 |
92 | MP0002118_abnormal_lipid_homeostasis | 0.75449287 |
93 | MP0000689_abnormal_spleen_morphology | 0.75367013 |
94 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.74673777 |
95 | MP0001765_abnormal_ion_homeostasis | 0.73867132 |
96 | MP0004019_abnormal_vitamin_homeostasis | 0.73335313 |
97 | MP0001835_abnormal_antigen_presentation | 0.72866819 |
98 | MP0002420_abnormal_adaptive_immunity | 0.72696591 |
99 | MP0008874_decreased_physiological_sensi | 0.71685760 |
100 | MP0001819_abnormal_immune_cell | 0.71426494 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Pigmentary retinal degeneration (HP:0001146) | 5.00620984 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.18075673 |
3 | Aplasia/hypoplasia of the uterus (HP:0008684) | 4.07466067 |
4 | Hypoplasia of the uterus (HP:0000013) | 3.93144463 |
5 | Abnormality of glycolipid metabolism (HP:0010969) | 3.82153438 |
6 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.82153438 |
7 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.82153438 |
8 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.73857911 |
9 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.53783738 |
10 | Acute necrotizing encephalopathy (HP:0006965) | 3.53690318 |
11 | Acute encephalopathy (HP:0006846) | 3.35875072 |
12 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.31215118 |
13 | Mitochondrial inheritance (HP:0001427) | 3.26066787 |
14 | Hypomagnesemia (HP:0002917) | 3.18057860 |
15 | Progressive macrocephaly (HP:0004481) | 3.07149858 |
16 | Choroideremia (HP:0001139) | 3.05554800 |
17 | B lymphocytopenia (HP:0010976) | 3.03413846 |
18 | Increased circulating renin level (HP:0000848) | 2.99640909 |
19 | Hepatic necrosis (HP:0002605) | 2.99303927 |
20 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.96450353 |
21 | Increased CSF lactate (HP:0002490) | 2.93684000 |
22 | Abnormality of lateral ventricle (HP:0030047) | 2.92553016 |
23 | Abnormality of magnesium homeostasis (HP:0004921) | 2.91324037 |
24 | Interstitial pulmonary disease (HP:0006530) | 2.80793091 |
25 | Tetany (HP:0001281) | 2.76727287 |
26 | Hepatocellular necrosis (HP:0001404) | 2.76523030 |
27 | Hypothermia (HP:0002045) | 2.75956857 |
28 | Acute hepatic failure (HP:0006554) | 2.57880235 |
29 | Prolonged neonatal jaundice (HP:0006579) | 2.55880304 |
30 | Vacuolated lymphocytes (HP:0001922) | 2.55686053 |
31 | Increased hepatocellular lipid droplets (HP:0006565) | 2.53711945 |
32 | Renal Fanconi syndrome (HP:0001994) | 2.51159367 |
33 | Increased intramyocellular lipid droplets (HP:0012240) | 2.49265841 |
34 | Abnormality of B cell number (HP:0010975) | 2.48645171 |
35 | Gastrointestinal infarctions (HP:0005244) | 2.44496758 |
36 | Mutism (HP:0002300) | 2.43282579 |
37 | Agammaglobulinemia (HP:0004432) | 2.43067760 |
38 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.37835438 |
39 | Ileus (HP:0002595) | 2.31654337 |
40 | Attenuation of retinal blood vessels (HP:0007843) | 2.30169331 |
41 | Arthropathy (HP:0003040) | 2.30069465 |
42 | Prolonged partial thromboplastin time (HP:0003645) | 2.29017173 |
43 | Hyperglycemia (HP:0003074) | 2.28856143 |
44 | Episodic fever (HP:0001954) | 2.27154722 |
45 | Progressive neurologic deterioration (HP:0002344) | 2.23076316 |
46 | Glycosuria (HP:0003076) | 2.20098066 |
47 | Abnormality of urine glucose concentration (HP:0011016) | 2.20098066 |
48 | Flat capital femoral epiphysis (HP:0003370) | 2.19437508 |
49 | Dysostosis multiplex (HP:0000943) | 2.18438791 |
50 | Palpitations (HP:0001962) | 2.16290890 |
51 | Ketoacidosis (HP:0001993) | 2.16053742 |
52 | Aplastic anemia (HP:0001915) | 2.12857404 |
53 | Generalized aminoaciduria (HP:0002909) | 2.12410113 |
54 | Lipid accumulation in hepatocytes (HP:0006561) | 2.09335137 |
55 | Cerebral edema (HP:0002181) | 2.03105690 |
56 | Hyperphosphaturia (HP:0003109) | 2.01044297 |
57 | Reduced antithrombin III activity (HP:0001976) | 1.99758462 |
58 | Increased muscle lipid content (HP:0009058) | 1.98695675 |
59 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.96911139 |
60 | Basal ganglia calcification (HP:0002135) | 1.96675060 |
61 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.96338415 |
62 | Irregular vertebral endplates (HP:0003301) | 1.96243941 |
63 | Large for gestational age (HP:0001520) | 1.94701896 |
64 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.93926963 |
65 | Lactic acidosis (HP:0003128) | 1.93795678 |
66 | Hypoglycemic coma (HP:0001325) | 1.92818514 |
67 | Infantile muscular hypotonia (HP:0008947) | 1.91255979 |
68 | Abnormal number of erythroid precursors (HP:0012131) | 1.90497762 |
69 | Joint stiffness (HP:0001387) | 1.89708378 |
70 | Skin rash (HP:0000988) | 1.87736642 |
71 | Nuclear cataract (HP:0100018) | 1.87260885 |
72 | Metaphyseal irregularity (HP:0003025) | 1.87020959 |
73 | Hypoglycemic seizures (HP:0002173) | 1.86234007 |
74 | Tachypnea (HP:0002789) | 1.84920330 |
75 | Delayed CNS myelination (HP:0002188) | 1.84795096 |
76 | Respiratory failure (HP:0002878) | 1.84507269 |
77 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.81579827 |
78 | Increased serum lactate (HP:0002151) | 1.78092167 |
79 | Retinal dysplasia (HP:0007973) | 1.77295225 |
80 | Increased corneal curvature (HP:0100692) | 1.76516395 |
81 | Keratoconus (HP:0000563) | 1.76516395 |
82 | Severe visual impairment (HP:0001141) | 1.76301584 |
83 | Male infertility (HP:0003251) | 1.74890499 |
84 | Polydipsia (HP:0001959) | 1.74849993 |
85 | Abnormal drinking behavior (HP:0030082) | 1.74849993 |
86 | Tongue fasciculations (HP:0001308) | 1.74744911 |
87 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.72392913 |
88 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.72392913 |
89 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.71509869 |
90 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.71509869 |
91 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.71509869 |
92 | Azoospermia (HP:0000027) | 1.68454512 |
93 | Abnormal urine phosphate concentration (HP:0012599) | 1.66963013 |
94 | Hypokinesia (HP:0002375) | 1.66874115 |
95 | Postural tremor (HP:0002174) | 1.66857349 |
96 | Decreased central vision (HP:0007663) | 1.65619529 |
97 | Lethargy (HP:0001254) | 1.64769056 |
98 | Abnormality of midbrain morphology (HP:0002418) | 1.62273453 |
99 | Molar tooth sign on MRI (HP:0002419) | 1.62273453 |
100 | Abnormal spermatogenesis (HP:0008669) | 1.61351044 |
Rank | Gene Set | Z-score |
---|---|---|
1 | PRKD3 | 4.07368279 |
2 | ERN1 | 3.58300370 |
3 | LMTK2 | 3.43244207 |
4 | INSRR | 3.28121845 |
5 | EIF2AK1 | 3.08434379 |
6 | FLT3 | 2.68826740 |
7 | NME2 | 2.57321407 |
8 | IRAK3 | 2.54621381 |
9 | EPHA3 | 2.49904808 |
10 | MAP3K11 | 2.30917148 |
11 | VRK2 | 2.20419128 |
12 | STK16 | 2.11216511 |
13 | ADRBK2 | 2.09454958 |
14 | EIF2AK3 | 2.06069959 |
15 | LIMK1 | 2.02008415 |
16 | EPHB1 | 1.96877046 |
17 | GRK1 | 1.96573547 |
18 | MST4 | 1.83172413 |
19 | MAPKAPK3 | 1.80658015 |
20 | PKN2 | 1.79706701 |
21 | NME1 | 1.70300002 |
22 | TBK1 | 1.47439961 |
23 | ARAF | 1.46379511 |
24 | MAP3K12 | 1.41414705 |
25 | MAP3K1 | 1.41157766 |
26 | PIM2 | 1.41000397 |
27 | FRK | 1.39027569 |
28 | MAP2K6 | 1.35982316 |
29 | KDR | 1.34094007 |
30 | PRKG2 | 1.26294545 |
31 | SCYL2 | 1.21593853 |
32 | TAOK3 | 1.15610098 |
33 | FER | 1.14824839 |
34 | CDK8 | 1.14710896 |
35 | MAP4K1 | 1.14633852 |
36 | MYLK | 1.05498400 |
37 | PHKG1 | 1.03829677 |
38 | PHKG2 | 1.03829677 |
39 | NLK | 1.02464166 |
40 | BUB1 | 1.01075816 |
41 | TEC | 0.99556933 |
42 | HIPK2 | 0.96677541 |
43 | PLK2 | 0.95827574 |
44 | PASK | 0.94518625 |
45 | IKBKB | 0.93453157 |
46 | CAMK2D | 0.84775378 |
47 | IRAK1 | 0.81468865 |
48 | FGFR4 | 0.80176240 |
49 | KIT | 0.79866862 |
50 | CSNK1G3 | 0.79428111 |
51 | GRK6 | 0.78421126 |
52 | MAP4K2 | 0.75897038 |
53 | BCKDK | 0.75617598 |
54 | RPS6KA5 | 0.71872796 |
55 | IRAK4 | 0.71449659 |
56 | SYK | 0.71024442 |
57 | PAK4 | 0.69574385 |
58 | TESK1 | 0.66751613 |
59 | GRK5 | 0.65640343 |
60 | CAMK2G | 0.63988220 |
61 | CSNK1G2 | 0.62863548 |
62 | TLK1 | 0.62481787 |
63 | CSNK1G1 | 0.62451970 |
64 | DAPK1 | 0.61501640 |
65 | PRKD2 | 0.59549691 |
66 | PRKCE | 0.58118673 |
67 | ITK | 0.57734042 |
68 | NTRK3 | 0.56281475 |
69 | RET | 0.55793266 |
70 | CSF1R | 0.55319816 |
71 | GRK7 | 0.54224483 |
72 | ZAP70 | 0.52944739 |
73 | STK3 | 0.52702779 |
74 | WNK4 | 0.51850427 |
75 | PRKCI | 0.46962387 |
76 | IKBKE | 0.46667095 |
77 | MATK | 0.45885462 |
78 | NUAK1 | 0.45126035 |
79 | ABL1 | 0.44845574 |
80 | TRPM7 | 0.43524471 |
81 | CSNK1A1 | 0.42454425 |
82 | LYN | 0.42335816 |
83 | BTK | 0.41931110 |
84 | JAK3 | 0.38574094 |
85 | STK24 | 0.37589436 |
86 | MOS | 0.36448513 |
87 | CSNK1A1L | 0.35088360 |
88 | FGFR3 | 0.34848373 |
89 | PAK1 | 0.33801101 |
90 | TESK2 | 0.33470946 |
91 | JAK1 | 0.32457727 |
92 | PRKCD | 0.30898439 |
93 | CDK4 | 0.30890000 |
94 | MAPKAPK2 | 0.30745579 |
95 | MAP3K6 | 0.29585177 |
96 | PTK2B | 0.28025742 |
97 | ROCK1 | 0.27710464 |
98 | CAMK2B | 0.27386494 |
99 | TGFBR1 | 0.24730337 |
100 | JAK2 | 0.23711418 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Proteasome_Homo sapiens_hsa03050 | 4.62629674 |
2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.79688111 |
3 | Sulfur metabolism_Homo sapiens_hsa00920 | 3.77167783 |
4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.71410012 |
5 | Parkinsons disease_Homo sapiens_hsa05012 | 2.69928178 |
6 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.59626762 |
7 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 2.16994849 |
8 | Protein export_Homo sapiens_hsa03060 | 2.14769102 |
9 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.13976302 |
10 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 2.12313053 |
11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.95601156 |
12 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.92809525 |
13 | Peroxisome_Homo sapiens_hsa04146 | 1.89126288 |
14 | Alzheimers disease_Homo sapiens_hsa05010 | 1.87634644 |
15 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.87406294 |
16 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.85466971 |
17 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.83731831 |
18 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.69489276 |
19 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.68899573 |
20 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.67619794 |
21 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.65559934 |
22 | Mineral absorption_Homo sapiens_hsa04978 | 1.62499090 |
23 | Huntingtons disease_Homo sapiens_hsa05016 | 1.59445297 |
24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.38292769 |
25 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.36822037 |
26 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.35722464 |
27 | RNA polymerase_Homo sapiens_hsa03020 | 1.33216073 |
28 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.31726893 |
29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.27930170 |
30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.25773993 |
31 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.22994720 |
32 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.21374446 |
33 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.14601153 |
34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.13329475 |
35 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.05176784 |
36 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02940658 |
37 | Taste transduction_Homo sapiens_hsa04742 | 1.02784738 |
38 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.98881604 |
39 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.98591611 |
40 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.98078052 |
41 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.97652700 |
42 | Lysosome_Homo sapiens_hsa04142 | 0.96424614 |
43 | Legionellosis_Homo sapiens_hsa05134 | 0.94270825 |
44 | Homologous recombination_Homo sapiens_hsa03440 | 0.92703887 |
45 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.92553211 |
46 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.92243619 |
47 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.91969818 |
48 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.89744714 |
49 | Ribosome_Homo sapiens_hsa03010 | 0.84185733 |
50 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.83544968 |
51 | Metabolic pathways_Homo sapiens_hsa01100 | 0.81972551 |
52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.80853041 |
53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.79402646 |
54 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.77353306 |
55 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.76270993 |
56 | Purine metabolism_Homo sapiens_hsa00230 | 0.75583097 |
57 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.72751172 |
58 | Malaria_Homo sapiens_hsa05144 | 0.72368676 |
59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.70063047 |
60 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.68754979 |
61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.68042215 |
62 | Pertussis_Homo sapiens_hsa05133 | 0.63907942 |
63 | RNA degradation_Homo sapiens_hsa03018 | 0.63083646 |
64 | Measles_Homo sapiens_hsa05162 | 0.62939468 |
65 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.62937236 |
66 | Mismatch repair_Homo sapiens_hsa03430 | 0.62812754 |
67 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.62789984 |
68 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.62317632 |
69 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.60641122 |
70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59864142 |
71 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.58476731 |
72 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.57372769 |
73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.56016043 |
74 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.55211976 |
75 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.52549597 |
76 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.51751147 |
77 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49356822 |
78 | Base excision repair_Homo sapiens_hsa03410 | 0.48582242 |
79 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46055417 |
80 | Shigellosis_Homo sapiens_hsa05131 | 0.45946160 |
81 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.45595772 |
82 | Retinol metabolism_Homo sapiens_hsa00830 | 0.45411266 |
83 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45169323 |
84 | Asthma_Homo sapiens_hsa05310 | 0.44153832 |
85 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.43616154 |
86 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.43579738 |
87 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.43350009 |
88 | Prion diseases_Homo sapiens_hsa05020 | 0.39551028 |
89 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.37830762 |
90 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.36768992 |
91 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.33390155 |
92 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.33348871 |
93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.33143077 |
94 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.31823372 |
95 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.28536971 |
96 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.28313088 |
97 | Histidine metabolism_Homo sapiens_hsa00340 | 0.27679794 |
98 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22109450 |
99 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.21819858 |
100 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.20439719 |